Heparin sodium,low molecular weight heparins (CAS 9041-08-1) Market Research Report 2024

April 2024 | 70 pages | ID: H3334004D50EN
BAC Reports

Abstracts

Heparin sodium,low molecular weight heparins (CAS 9041-08-1) Market Research Report 2024 presents comprehensive data on Heparin sodium markets globally and regionally (Europe, Asia, North America etc.)

The report includes Heparin sodium description, covers its application areas and related patterns. It overviews Heparin sodium market, names Heparin sodium producers and indicates its suppliers.

Besides, the report provides Heparin sodium prices in regional markets.

In addition to the above the report determines Heparin sodium consumers in the market.

BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).

We can analyze the following elements for each chemical product in any country or region:

• capacities and production
• consumption volume and structure
• market price trends
• exports and imports
• existing technologies
• feedstock market condition
• market news digest
• market forecast.

Heparin sodium,low molecular weight heparins (CAS 9041-08-1) Market Research Report 2024 can feature:

• market condition and estimations, market forecast
• chemical product ranges, trademarks, analogous products, application areas
• regional and global producers, consumers and traders (including contact details).

Contents

1. HEPARIN SODIUM (CAS 9041-08-1)

1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information

2. HEPARIN SODIUM APPLICATIONS

2.1. Heparin sodium application spheres, downstream products

3. HEPARIN SODIUM MANUFACTURING METHODS

4. HEPARIN SODIUM PATENTS

Abstract
Description
Summary of the invention
Detailed description of the invention

5. HEPARIN SODIUM MARKET WORLDWIDE 

5.1. General Heparin sodium market situation, trends
5.2. Manufacturers of Heparin sodium
- Europe
- Asia
- North America
- Other regions
5.3. Heparin sodium suppliers (importers, local distributors)
- Europe
- Asia
- North America
- Other regions
5.4. Heparin sodium market forecast

6. HEPARIN SODIUM MARKET PRICES

6.1. Heparin sodium prices in Europe
6.2. Heparin sodium prices in Asia
6.3. Heparin sodium prices in North America
6.4. Heparin sodium prices in other regions

7. HEPARIN SODIUM END-USE SECTOR 

7.1. Heparin sodium market by application sphere
7.2. Heparin sodium downstream markets trends and prospects

*Please note that Heparin sodium,low molecular weight heparins (CAS 9041-08-1) Market Research Report 2024 is a half ready publication and contents are subject to change. It only requires updating with the help of new data that are constantly retrieved from Publisher’s databases and other sources. This updating process takes 5-7 business days after order is placed. Thus, our clients always obtain a revised and updated version of each report. Please also note that we do not charge for such an updating procedure. BAC Reports has information for more than 25,000 different chemicals available but it is impossible to have all reports updated immediately. That is why it takes 5-7 days to update a report after an order is received.

About

Product Name:	Heparin sodium
Synonyms:	Ardeparin sodium Dalteparin sodium Enoxaparin sodium Heparin,compounds,sodium salt Heparin HEPARIN SODIUM SALT Heparin Sodium Sodium acid heparin Heparin Sodium BP Heparin sodium,low molecular weight heparins
CAS#:	9041-08-1
Formula:	(C12H16NS2Na3)20
Appearance:	Odorless white to off-white solid or liquid
Usage:	Anticlotting agent.

Heparin sodium (Alfa87-120; Alfa 87-163; Alfa 87-198; Alfa 87-81; Alfa 88-247; Ardeparin sodium; Badyket; Clivarin 1750; Fragmin; Fragmin IV; H 2149; Hed-Heparin; Hepaflush; Hepagumin; Hepalean; Heparin Fragment Kabi 2165; Heparin sodium; HeparineChoay; Heprinar; Hepsal; Ivor; Kabi 2165; LHN 1; Lioton1000; etc.) refers to a complex glycosaminoglycan that is composed of alternate sequences of uronic acid -D-glucosamine linked by bonds. In heparin sodium, the acidic protons of the sulfate units are partially replaced by sodium ions.

Heparin sodium is a white odorless solid with the molecular formula (C₁₂H₁₆NS₂Na₃)20. The product is 5% soluble in water.

Heparin sodium exhibits a lot of uses, however, it is most widely used as an anticoagulant. The product is utilized to prevent or decrease blood clotting during different kinds of surgeries and during dialysis. Heparin sodium prevents clots of blood from forming and becoming larger. Furthermore, the product is used in veterinary for treatment of thromboembolic disease, pancreatitis, laminitis, endotoxic shock and burns. The treatment of acute phase myocardial infartus, pulmonary embolism, atherosclerosis, deep phlebitis, etc. are amid other applications of heparin sodium.

The product causes potential health effects such as transient eye irritation, hemorrhage at multiple sites, respiratory and kidney abnormalities, anemia, and cardiovascular collapse. Gastrointestinal irritation, nausea, vomiting and diarrhea are also amid the side effects of heparin sodium.

Heparin sodium market is covered in the study Heparin sodium, low molecular weight heparins (CAS 9041-08-1) Market Research Report 2023. The report encompasses proper description of the product, unveils application areas, and briefly summarizes patents in the sphere. It overlooks heparin sodium market situation, names manufacturers, suppliers as well as users. The report also provides current heparin sodium prices in the market.